M&A Snapshot: GSK to acquire IDRx in $1.15B deal, expanding in GI cancer therapy
M&A Snapshot: GSK to acquire IDRx in $1.15B deal, expanding in GI cancer therapy
Posted by Posted by Posted by Posted by Posted by
M&A Snapshot: GSK to acquire IDRx in $1.15B deal, expanding in GI cancer therapy